Patrick Rodrigus

3.8k total citations · 1 hit paper
31 papers, 2.9k citations indexed

About

Patrick Rodrigus is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Patrick Rodrigus has authored 31 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 9 papers in Radiation. Recurrent topics in Patrick Rodrigus's work include Lung Cancer Treatments and Mutations (11 papers), Advanced Radiotherapy Techniques (9 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Patrick Rodrigus is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Advanced Radiotherapy Techniques (9 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Patrick Rodrigus collaborates with scholars based in Netherlands, Belgium and United States. Patrick Rodrigus's co-authors include Harry Bartelink, Nico van Zandwijk, Walter Van den Bogaert, Jan Festen, C. Schaake-Koning, B. Maat, Jean‐Paul Sculier, Otilia Dalesio, A. Renaud and Anne Kirkpatrick and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Patrick Rodrigus

31 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1992 998 citations C. Schaake-Koning, Walter Van den Bogaert et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Rodrigus Netherlands	19	1.9k	1.0k	877	729	438	31	2.9k
Kwan Ho Cho South Korea	29	1.3k 0.7×	637 0.6×	970 1.1×	755 1.0×	538 1.2×	104	2.6k
Cornelius J. McGinn United States	27	1.5k 0.8×	1.6k 1.6×	761 0.9×	550 0.8×	711 1.6×	38	3.3k
J. Chavaudra France	25	1.1k 0.6×	454 0.4×	821 0.9×	802 1.1×	210 0.5×	78	2.3k
Giuseppe Roberto D’Agostino Italy	30	1.1k 0.6×	669 0.7×	512 0.6×	396 0.5×	607 1.4×	125	2.4k
Seung Jae Huh South Korea	34	814 0.4×	821 0.8×	434 0.5×	682 0.9×	975 2.2×	154	3.2k
Chad G. Rusthoven United States	29	1.7k 0.9×	1.0k 1.0×	417 0.5×	477 0.7×	272 0.6×	104	2.4k
Devin Schellenberg Canada	20	1.0k 0.6×	1.0k 1.0×	762 0.9×	522 0.7×	452 1.0×	70	2.0k
Daniela Greto Italy	22	797 0.4×	571 0.6×	385 0.4×	397 0.5×	319 0.7×	126	1.8k
Rachelle Lanciano United States	37	1.0k 0.5×	939 0.9×	765 0.9×	556 0.8×	1.6k 3.7×	109	4.1k
Alan Nichol Canada	29	1.1k 0.6×	572 0.6×	1.0k 1.2×	712 1.0×	381 0.9×	112	2.4k

Countries citing papers authored by Patrick Rodrigus

Since Specialization

Citations

This map shows the geographic impact of Patrick Rodrigus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Rodrigus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Rodrigus more than expected).

Fields of papers citing papers by Patrick Rodrigus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Rodrigus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Rodrigus. The network helps show where Patrick Rodrigus may publish in the future.

Co-authorship network of co-authors of Patrick Rodrigus

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Rodrigus. A scholar is included among the top collaborators of Patrick Rodrigus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Rodrigus. Patrick Rodrigus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meijer, Gert J., K Bzdusek, Hetty A. van den Berg, et al.. (2008). What CTV-to-PTV Margins Should Be Applied for Prostate Irradiation? Four-Dimensional Quantitative Assessment Using Model-Based Deformable Image Registration Techniques. International Journal of Radiation Oncology*Biology*Physics. 72(5). 1416–1425. 56 indexed citations

Ruysscher, Dirk De, Johan Bussink, Patrick Rodrigus, et al.. (2007). Concurrent celecoxib versus placebo in patients with stage II–III non-small cell lung cancer: A randomised phase II trial. Radiotherapy and Oncology. 84(1). 23–25. 11 indexed citations

Vulto, Arnold G., Marieke W.J. Louwman, Patrick Rodrigus, & J.W.W. Coebergh. (2006). Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988–2002. Radiotherapy and Oncology. 78(2). 131–137. 28 indexed citations

Belderbos, J., Nico van Zandwijk, Huub Belderbos, et al.. (2006). Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). European Journal of Cancer. 43(1). 114–121. 141 indexed citations

Belt‐Dusebout, Alexandra W. van den, Janine Nuver, Ronald de Wit, et al.. (2006). Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer. Journal of Clinical Oncology. 24(3). 467–475. 246 indexed citations

Steenbakkers, Roel J.H.M., J. Duppen, Isabelle Fitton, et al.. (2005). Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis. International Journal of Radiation Oncology*Biology*Physics. 64(2). 435–448. 222 indexed citations

Poortmans, P., H. Bartelink, H. Struikmans, et al.. (2004). The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial. European Journal of Cancer Supplements. 2(3). 148–148. 18 indexed citations

Poortmans, Philip, Harry Bartelink, Jean-Claude Horiot, et al.. (2004). The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomised trial. Radiotherapy and Oncology. 72(1). 25–33. 114 indexed citations

Mehta, Minesh P., Patrick Rodrigus, Chris H.J. Terhaard, et al.. (2001). Impairment of neurocognitive function in brain metastases patients: baseline results from the phase III trial with motexafin gadolinium. International Journal of Radiation Oncology*Biology*Physics. 51(3). 135–136. 1 indexed citations

10.

Rodrigus, Patrick, et al.. (2001). Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation. Lung Cancer. 32(2). 129–136. 71 indexed citations

11.

Uitterhoeve, A. L. J., J. Belderbos, Marijn Koolen, et al.. (2000). Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer. European Journal of Cancer. 36(5). 592–600. 49 indexed citations

12.

Rodrigus, Patrick. (1999). The impact of surgical adjuvant thoracic radiation for different stages of non-small cell lung cancer: the experience from a single institution. Lung Cancer. 23(1). 11–17. 7 indexed citations

13.

Brekelmans, Cecile T.M., Adri C. Voogd, Bert N. van Geel, et al.. (1999). Family history of breast cancer and local recurrence after breast-conserving therapy. European Journal of Cancer. 35(4). 620–626. 27 indexed citations

14.

Kruitwagen, Roy F.P.M., et al.. (1997). Hematometra after Radiotherapy for Cervical Carcinoma. Gynecologic Oncology. 67(3). 325–327. 2 indexed citations

15.

Rodrigus, Patrick, et al.. (1997). Evaluation of late morbidity in patients with carcinoma of the uterine cervix following a dose rate change. Radiotherapy and Oncology. 42(2). 137–141. 30 indexed citations

16.

Bel, Arjan, Pieter H. Vos, Patrick Rodrigus, et al.. (1996). High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. International Journal of Radiation Oncology*Biology*Physics. 35(2). 321–332. 168 indexed citations

17.

Vos, Pieter H., et al.. (1994). Set-up accuracy for pelvic fields after application of a 3-d correction procedure using digital portal imaging. International Journal of Radiation Oncology*Biology*Physics. 30. 228–229. 3 indexed citations

18.

Schaake-Koning, C., W. Van den Bogaert, Otilia Dalesio, et al.. (1993). Radiotherapy combined with low-dose cisplatin; results of the EORTC 08844 phase III study by the EORTC Radiotherapy and Lung Cancer Cooperative Groups. Lung Cancer. 9(1-6). 245–248. 2 indexed citations

19.

Rodrigus, Patrick & A.A.J. van Landeghem. (1992). Prostate specific antigen levels during and after external beam radiotherapy for localized carcinoma of the prostate: predictor of therapeutic efficacy.. PubMed. 168(7). 397–401. 5 indexed citations

20.

Schaake-Koning, C., Walter Van den Bogaert, Otilia Dalesio, et al.. (1992). Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer. New England Journal of Medicine. 326(8). 524–530. 998 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact